Wegovy Wins English Funding For Weight Loss As Novo Deals With Supply Issues

Unprecedented demand for Wegovy in the US, together with issues experienced at the contract manufacturing site that resulted in supply shortages, led to Novo Nordisk having to wait some time for NICE to publish its final recommendation for the drug’s use on the National Health Service in England.